EFMC-ISMC 2014 - XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014)
Organization: European Federation for Medicinal Chemistry (EFMC)
Venue: Lisboa Congress Center
|Event Date/Time: Sep 07, 2014||End Date/Time: Sep 11, 2014|
|Early Registration Date: Mar 25, 2014|
|Abstract Submission Date: Mar 25, 2014|
|Paper Submission Date: Jun 17, 2014|
The XXIII International Symposium on Medicinal Chemistry (EFMC-ISMC 2014) will be organised by the Group of Medicinal Chemistry of the (SPQ) on behalf of the (EFMC). The symposium will take place at the Lisbon Congress Center from September 7-11, 2014. The biennial “EFMC International Symposium on Medicinal Chemistry” (EFMC-ISMC) is a key Symposium in its field and attracts traditionally between 1200 and 1400 participants, from industry and academia. Recent EFMC-ISMC meetings have been organised in different countries including Denmark (Copenhagen/Malmö, 2004), Turkey (Istanbul, 2006), Austria (Vienna, 2008), Belgium (Brussels, 2010) and the most recent one in Germany (Berlin, 2012).
The 2014 edition will continue the tradition established by these biennial symposia and will cover drug discovery advances in the major therapeutic areas, including neglected diseases, CNS disorders, inflammation, metabolic disorders, and oncology. EFMC-ISMC 2014 will present the most recent advances in lead identification and optimization strategies, drug design and profiling technologies, and illustrate the impact of biomarkers and imaging at the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and organic synthesis which had a strong impact on medicinal chemistry.
This symposium is recognised worldwide as one of the leading Medicinal Chemistry meetings, as proven by its large international attendance.
EFMC-ISMC can be considered as one of the leading Medicinal Chemistry meetings worldwide. Indeed, it attracts a highly targeted audience composed of experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. For five days, Lisbon will be the setting of an international scientific meeting. For companies active in the field of Medicinal Chemistry the Symposium represents an excellent opportunity to promote the quality of their scientific activities and to confirm their support to the discipline itself.
For any further information regarding the available sponsorship and exhibition opportunities, please get in touch with us at secretariat(at)efmc-ismc.org